Veeva Services Market Overview

As an increasing number of pharmaceutical companies experiment with different ways to cut costs while boosting productivity amid the pandemic, the industry is increasingly switching to cloud-based technologies. In this scenario, Veeva has become indispensable for the life sciences industry, helping life sciences enterprises manage customer databases, track drug developments, and organize clinical trials.

Veeva entered the life sciences market with its Commercial Cloud business, including the core Customer Relationship Management (CRM) offering, which has now transitioned into a mature product with a market share of about 80% across all global pharmaceutical companies. Lately, Veeva has been experiencing increasing demand for its Development Cloud (R&D) suite, which now drives more than half of its total revenue.

This report focuses on changing market dynamics, emerging service provider trends, and guidance on devising the right market entry strategy for Veeva services